Company to Participate in Upcoming ConferencesWASHINGTON, July 11, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after market close, with a conference call to follow at 5 p.m. ET.Shareholders and interested participants may listen to a ...

Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's specialty condition management platform through AI-enabled clinical workflow automationMachinify technology leverages the latest advances in applied machine learning, large language models and data analyticsAcquisition expected to benefit health plans, clinicians, and membersWASHINGTON, June 4, 2024 /PRNewswire/ -- Evolent Health, Inc. ("Evolent" or "the Company"), (NYSE: EVH) a company focused on achieving bette ...

Evolent Health (EVH) reported $639.65 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 49.6%. EPS of $0.34 for the same period compares to $0.21 a year ago.The reported revenue represents a surprise of +6.33% over the Zacks Consensus Estimate of $601.6 million. With the consensus EPS estimate being $0.21, the EPS surprise was +61.90%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall S ...

财务数据和关键指标变化 - 公司第一季度收入为6.397亿美元,同比增长49.6%,超出公司指引的上限近3000万美元 [12] - 公司专业医疗服务业务收入占总收入的91%,较3年前的60%有大幅提升 [13] - 公司平均拥有3990万独立会员,较上一季度有所增加 [14] - 公司调整后EBITDA为5410万美元,符合公司指引中值 [15] - 公司现金及等价物余额为1.651亿美元 [15] 各条业务线数据和关键指标变化 - 公司专业医疗服务业务收入同比增长约69%,剔除收购影响后增长约62% [13] - 公司专业医疗服务业务收入占比持续提升,从3年前的60%增至91% [13] 各个市场数据和关键指标变化 - 公司在Molina的合作范围扩大至9个州,新增南卡罗来纳州和密西西比州 [16][17][18] - 公司与一家东海岸的长期Medicaid合作伙伴签约,提供肌肉骨骼专业服务 [20] 公司战略和发展方向及行业竞争 - 公司专业医疗服务业务保持高速增长,体现了客户对公司解决方案的信任 [41] - 行业内医疗费用上升压力加剧,促使医疗保险公司更加关注专科管理 [24][25] - 公司销售渠道保持强劲,来自区域和全国性医保公司的需求旺盛 [24][25] 管理层对经营环境和未来前景的评论 - 管理层认为公司专业医疗服务平台具有差异化优势,未来发展前景乐观 [41][42][43] - 管理层表示,公司将继续投资人工智能等技术创新,以提高服务质量和效率 [28][29] 问答环节重要的提问和回答 问题1 **Kyle Aikman 提问** 询问宏观医保环境对公司业务的影响,是否加速了销售进程 [71][72][73][74] **Seth Blackley 回答** 医保公司面临多重压力,专科管理成为其关注的重点,增加了对公司解决方案的需求 [72][73][74] 问题2 **Jeff Garro 提问** 询问公司合同中的价格调整条款的执行时间 [77][78][79] **Seth Blackley 和 John Johnson 回答** 公司合同中通常有明确的价格调整机制,根据具体情况3-12个月内完成调整 [78][79][82][83] 问题3 **Jessica Tassan 提问** 确认公司在本季度确认了2023年绩效年度的MSSP分享收益 [89][90][91][92] **John Johnson 回答** 公司每季度都会根据最新数据对MSSP分享收益进行调整,第三季度会确认最终结算数据 [90][91][92]

Evolent Health (EVH) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 61.90%. A quarter ago, it was expected that this health care software and consulting services provider would post earnings of $0.11 per share when it actually produced earnings of $0.23, delivering a surprise of 109. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) S QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37415 _________________________ Evolent Health, Inc. (Exact name of registr ...

Exhibit 99.1 Evolent Announces First Quarter 2024 Results • Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023. • Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) million and a net loss margin of (3.9)%. • Adjusted EBITDA of $54.1 million resulting in an Adjusted EBITDA margin of 8.5%. • Raises revenue outlook for full year 2024 and reiterates full year 2024 Adjusted EBITDA guidance. WASHINGTON (May 9, 2024) – Evolent ...

Company to Participate in Upcoming Conferences WASHINGTON, April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after market close, with a conference call to follow at 5 p.m. ET. Shareholders and interested participants may listen to a li ...

Shares of Evolent Health (EVH) have gained 9.4% over the past four weeks to close the last trading session at $33.75, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.38 indicates a potential upside of 34.5%.The mean estimate comprises 13 short-term price targets with a standard deviation of $7.37. While the lowest estimate of $34 indicates a 0.7% increase from the current pr ...

Shares of Evolent Health (EVH) have gained 10% over the past four weeks to close the last trading session at $33.53, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.50 indicates a potential upside of 35.7%.The mean estimate comprises 12 short-term price targets with a standard deviation of $7.80. While the lowest estimate of $34 indicates a 1.4% increase from the current pri ...